Study Summary
This trial will compare the effects of two different drugs for pain relief after rib cartilage removal.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 1 Secondary · Reporting Duration: 7-10 days following the last administration of study treatment
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Xylocaine® Injection Group
1 of 2
Exparel® Injection Group
1 of 2
Active Control
Experimental Treatment
60 Total Participants · 2 Treatment Groups
Primary Treatment: Exparel · No Placebo Group · Phase 4
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
| New Jersey | 100.0% |
How old are they?
| 18 - 65 | 100.0% |
What site did they apply to?
| Mayo Clinic in Rochester | 100.0% |
What portion of applicants met pre-screening criteria?
| Did not meet criteria | 100.0% |
Frequently Asked Questions
Has Exparel acquired the official sanction of the Food and Drug Administration?
"There is a great deal of evidence backing the safety of Exparel, resulting in it being given a rating of 3. This Phase 4 trial indicates that this treatment has already been granted approval." - Anonymous Online Contributor
How many individuals are being recruited for this clinical trial?
"Affirmative. Clinicaltrials.gov records the latest information, which suggests that this particular clinical trial is actively recruiting participants from a single site - 60 in total since its initial posting on May 4th 2022 and last update on June 11th 2022." - Anonymous Online Contributor
Is it still possible to volunteer for this clinical investigation?
"According to the information on clinicaltrials.gov, this research study is in its active recruitment phase and was originally posted on May 4th 2022 before being revised on June 11th of the same year." - Anonymous Online Contributor